| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |